pyridoxal phosphate has been researched along with Diabetic Retinopathy in 3 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied predictors of homocysteine levels and correlations between homocysteine and (micro-)albuminuria, retinopathy, and history of cardiovascular disease in normotensive NIDDM subjects under stable metabolic control." | 7.70 | Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. ( Odekerken, DA; Rakic, M; Sijbrands, EJ; Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; Treskes, M, 1999) |
| "We studied predictors of homocysteine levels and correlations between homocysteine and (micro-)albuminuria, retinopathy, and history of cardiovascular disease in normotensive NIDDM subjects under stable metabolic control." | 3.70 | Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. ( Odekerken, DA; Rakic, M; Sijbrands, EJ; Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; Treskes, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Tang, J | 1 |
| Lee, CA | 1 |
| Kern, TS | 1 |
| Yamagishi, S | 1 |
| Matsui, T | 1 |
| Nakamura, K | 1 |
| Yoshida, T | 1 |
| Takeuchi, M | 1 |
| Inoue, H | 1 |
| Yoshida, Y | 1 |
| Imaizumi, T | 1 |
| Smulders, YM | 1 |
| Rakic, M | 1 |
| Slaats, EH | 1 |
| Treskes, M | 1 |
| Sijbrands, EJ | 1 |
| Odekerken, DA | 1 |
| Stehouwer, CD | 1 |
| Silberbusch, J | 1 |
3 other studies available for pyridoxal phosphate and Diabetic Retinopathy
| Article | Year |
|---|---|
Metanx and early stages of diabetic retinopathy.
Topics: Animals; Contrast Sensitivity; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Folic Acid; I- | 2015 |
Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Topics: Adult; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; DNA Primers; | 2007 |
Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Topics: Administration, Oral; Adult; Aged; Albuminuria; Analysis of Variance; Blood Pressure; Cardiovascular | 1999 |